Kinnevik AB (publ)

Holdings History for RECURSION PHARMACEUTICALS, INC. - Class A Common Stock (RXRX)

Symbol: RXRX on Nasdaq
Investment type: Equity / Class A Common Stock

Shares, Excluding Options vs Price

Value, Excluding Options

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
30 Sep 2025	100%	0%	$65,558,755	13,434,171	0		$4.88	Q3 2025
30 Jun 2025	100%	0%	$67,976,906	13,434,171	0		$5.06	Q2 2025
31 Mar 2025	100%	+11%	$71,066,765	13,434,171	+1,528,503		$5.29	Q1 2025
31 Dec 2024	100%	0%	$80,482,316	11,905,668	0		$6.76	Q4 2024
30 Sep 2024	100%	0%	$78,458,352	11,905,668	0		$6.59	Q3 2024
30 Jun 2024	100%	+13%	$89,292,510	11,905,668	+1,500,000	+14%	$7.50	Q2 2024
31 Mar 2024	100%	0%	$103,744,510	10,405,668	0		$9.97	Q1 2024
31 Dec 2023	100%	0%	$102,599,886	10,405,668	0		$9.86	Q4 2023
30 Sep 2023	100%	0%	$79,603,360	10,405,668	0		$7.65	Q3 2023
30 Jun 2023	100%	+26%	$77,730,340	10,405,668	+2,752,607	+36%	$7.47	Q2 2023
31 Mar 2023	68%	0%	$51,045,917	7,653,061	0		$6.67	Q1 2023
31 Dec 2022	33%	+33%	$59,005,100	7,653,061	+7,653,061	NEW	$7.71	Q4 2022

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.